OCEANSIX-FUTURE-PATHS-LT
15.5.2024 12:49:30 CEST | Business Wire | Press release
oceansix future paths Ltd. (“oceansix” or the “Company”), a leader in advanced recycling and manufacturing technological solutions with a presence on the TSX Venture Exchange in Toronto (TSXV: CUSIP 001194828, OSIX), in New York (OTCQB: AKMYF), and Frankfurt Stock Exchange (WKN: A3EFB0, ISIN: IL0011948283, 5FC0), is pleased to announce that today it has entered into an asset purchase agreement (the “Agreement”) pursuant to which oceansix, through its subsidiary Oceansix S.L., has purchased the business of Original RePack Oy (“RePack”), a pioneer in reusable packaging systems with a decade of proven track record (the “Acquisition”). The Acquisition will allow the Company to reduce the reliance on single-use packaging in e-commerce deliveries, which is growing exponentially and reached an annual dispatch of 161 billion parcels in 2022.
Transaction Details
The total consideration for the Acquisition, based on the Company’s current share price, is valued by the parties at CDN $2,392,912. Pursuant to the Agreement, oceansix acquired the business of RePack in exchange for: (i) issuing 24,948,840 common shares in the capital of the Company (the “Shares”) to the shareholders of RePack; and (ii) a payment of USD $108,000 (the equivalent of CDN $147,517, based on current exchange rates) (the “Cash Payment”) on closing. 15,282,176 of the Shares were issued to the shareholders of RePack on closing of the Acquisition, with the balance to be issued to the shareholders of RePack in up to four subsequent installments, selected at the option of RePack.
The Acquisition is an arm’s length transaction. All Shares issued pursuant to the Agreement will be restricted from trading for four months and one day after issuance. The Agreement and Acquisition remain subject to the final approval of the TSX Venture Exchange (the “Exchange”). The price per share of Shares issued post-closing to shareholders of RePack will be subject to the Company’s share price at their time of issuance and calculated in accordance with the rules of the Exchange.
oceansix solidifies its commitment to reshaping the packaging Industry
“As a pioneering force in sustainable innovation and disruptive engineering, our recent acquisition of RePack marks a significant milestone in our journey towards a more sustainable future,” Elad Hameiri, CEO of oceansix, states. “Together with RePack we are entering the new era where packaging is used again and again.”
A Sustainable Satisfaction. Delivered.
RePack, now a central pillar in oceansix's mission, were the first ones who introduced reusable packaging to e-commerce. Jonne Hellgren, CEO of RePack, comments: "Together, we lead the movement against single-use packaging, by creating a true circular system. "Reduce. Reuse. RePack." becomes more than a slogan—it is our operational mantra."
A New Alliance for the End of Packaging Trash
This call to action reflects oceansix and RePack's shared vision for cleaner and more efficient deliveries. Jonne Hellgren emphasizes, "With oceansix, we will be able to make sustainability simple and engaging, creating a continuous loop of good. To make this happen it takes more than just a reusable product. It needs a truly circular, scalable system.”
Rebelling Against the Status Quo
The joint mission is unequivocally defined: to make reusable packaging very simple and convenient for retailers and their customers. “This collaboration is not a startup experiment, but a mature, credible, and scalable solution to revolutionize the e-commerce packaging industry,” emphasized Elad Hameiri, CEO of oceansix. RePack’s reusable packaging, backed by oceansix's 30 years of proven business execution and innovative proprietary technology, could finally become the standard solution to e-commerce packaging and put an end to single-use packaging trash. Hameiri accentuates: "It is not just a merger, it's a rebellion against the status quo.”
RePack Initiative: Keep Packing, Stop Trashing
Learn more about how oceansix and RePack are crafting the future of e-commerce by visiting our websites at oceansix.com and RePack.com. Connect with us on LinkedIn, Instagram to join our journey towards reducing packaging waste and creating more sustainable and engaging consumer experiences.
About oceansix
oceansix future paths Ltd. remains at the forefront of creating sustainable solutions that not only convert waste into valuable products but also advocate the principles of a circular economy. oceansix’s unwavering commitment to sustainability is intensified by its strategic alliance with RePack, magnifying its impact on global environmental challenges.
About RePack
RePack is more than just another reusable packaging supplier; they’re pioneers in revolutionising the way businesses approach packaging. Rather than simply selling packaging repeatedly, RePack is dedicated to establishing efficient reuse systems that eliminate the need for companies to constantly replenish their packaging supplies.
RePack’s mission is clear: to provide innovative reusable packaging solutions that not only shrink the environmental footprint of deliveries but also elevate the overall customer experience.
Disclaimer
This press release might include forward-looking statements based on current expectations and projections about future events. Generally, forward-looking statements and information may be identified by formulations using terms such as “expects”, “aims”, “anticipates”, “intends”, "plans", "believes", "seeks", "estimates" or "will". These are subject to risks, uncertainties, and changes in circumstances that may cause actual results to differ materially from those expressed or implied by such statements. In this press release, forward looking statements include statements regarding reducing the reliance on single-use packaging in e-commerce deliveries; the issuance of the balance of Shares; and receiving Exchange approval for closing the Acquisition. oceansix undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.
Approval & Accuracy
Neither TSX Venture Exchange nor its Regulation Services Provider (as defined in the policies of the TSX Venture Exchange) assumes responsibility for the adequacy or accuracy of this press release.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240515940303/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom